EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Liquid biopsy for improving diagnosis and monitoring of CNS lymphomas: A RANO review

Lakshmi Nayak, Chetan Bettegowda, Florian Scherer iD, Norbert Galldiks iD, Manmeet Ahluwalia, Alexander Baraniskin, Louisa von Baumgarten iD, Jacoline E C Bromberg iD, Andrés J M Ferreri, Christian Grommes, Khê Hoang-Xuan, Julia Kühn und 7 weitere

Neuro-Oncology · 03.06.2024 · 26 (6) · 993-1011

DOI: 10.1093/neuonc/noae032 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Neuro-Oncology, online erschienen am 10.04.2024. Verfasst von Lakshmi Nayak und 18 weiteren Autor:innen. Beteiligte Einrichtung: Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Central Nervous System Neoplasms, Lymphoma, Biomarkers, Tumor. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 153 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The utility of liquid biopsies is well documented in several extracranial and intracranial (brain/leptomeningeal metastases, gliomas) tumors.

Methods

The RANO (Response Assessment in Neuro-Oncology) group has set up a multidisciplinary Task Force to critically review the role of blood and cerebrospinal fluid (CSF)–liquid biopsy in CNS lymphomas, with a main focus on primary central nervous system lymphomas (PCNSL).

Results

Several clinical applications are suggested: diagnosis of PCNSL in critical settings (elderly or frail patients, deep locations, and steroid responsiveness), definition of minimal residual disease, early indication of tumor response or relapse following treatments, and prediction of outcome.

Conclusions

Thus far, no clinically validated circulating biomarkers for managing both primary and secondary CNS lymphomas exist. There is need of standardization of biofluid collection, choice of analytes, and type of technique to perform the molecular analysis. The various assays should be evaluated through well-organized central testing within clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Central Nervous System NeoplasmsLymphomaBiomarkers, TumorHumansLiquid BiopsyPrognosis

Stichwörter der Autor:innen

CSF biomarkersMYD88 mutationscirculating tumor DNAprimary CNS lymphomassecondary CNS lymphomas

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Department of Medicine I, Faculty of Medicine, Medical Center-University of Freiburg, University of Freiburg, Freiburg, Germany.
  • Department of Neurology, University of Cologne, Medical Faculty and University Hospital Cologne, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), and Institute of Neuroscience and Medicine (INM…
  • Rose and Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland OH and Miami Cancer Institute, Baptist Health South Florida, International University, Miami, Florida, USA.
  • Department of Hematology, Oncology and Palliative Care, Evangelisches Krankenhaus Hamm, Hamm, Germany.

ORCID-Profile: Florian Scherer, Norbert Galldiks, Louisa von Baumgarten, Jacoline E C Bromberg, Michael Weller, Martin J van den Bent, Patrick Y Wen, Riccardo Soffietti

Förderung

  • NCI NIH HHS

Zitieren

APA

Nayak, L., Bettegowda, C., Scherer, F., Galldiks, N., Ahluwalia, M., Baraniskin, A., von Baumgarten, L., Bromberg, J. E. C., Ferreri, A. J. M., Grommes, C., Hoang-Xuan, K., Kühn, J., Rubenstein, J. L., Rudà, R., Weller, M., Chang, S. M., van den Bent, M. J., Wen, P. Y., & Soffietti, R. (2024). Liquid biopsy for improving diagnosis and monitoring of CNS lymphomas: A RANO review. Neuro-Oncology, 26(6), 993-1011. https://doi.org/10.1093/neuonc/noae032

Vancouver

Nayak L, Bettegowda C, Scherer F, Galldiks N, Ahluwalia M, Baraniskin A, et al. Liquid biopsy for improving diagnosis and monitoring of CNS lymphomas: A RANO review. Neuro-Oncology. 2024;26(6):993-1011. doi:10.1093/neuonc/noae032

BibTeX
@article{Nayak2024,
  author = {Nayak, Lakshmi and Bettegowda, Chetan and Scherer, Florian and Galldiks, Norbert and Ahluwalia, Manmeet and Baraniskin, Alexander and von Baumgarten, Louisa and Bromberg, Jacoline E C and Ferreri, Andrés J M and Grommes, Christian and Hoang-Xuan, Khê and Kühn, Julia and Rubenstein, James L and Rudà, Roberta and Weller, Michael and Chang, Susan M and van den Bent, Martin J and Wen, Patrick Y and Soffietti, Riccardo},
  title = {Liquid biopsy for improving diagnosis and monitoring of CNS lymphomas: A RANO review},
  journal = {Neuro-Oncology},
  year = {2024},
  volume = {26},
  number = {6},
  pages = {993--1011},
  doi = {10.1093/neuonc/noae032}
}
Kostenlos starten →